Innovation

In May, we reported that Thomas Stossel, M.D., long a champion of physician and industry collaboration, has published a…

Thomas Stossel, American Cancer Society Professor of Medicine at Harvard Medical School and a visiting scholar at the American…

According to America Speaks, a compilation of public opinion polls commissioned by Research!America, the majority of Americans…

An interesting claim against the pharmaceutical industry (though usually made by only industry's most hardened critics) is that…

Recognizing that drug companies would actually incur a financial loss in developing important drugs for rare conditions,…

After more than a year of bipartisan work between Congressman Fred Upton (R-MI) and Congresswoman Diana DeGette (D-CO) on…

Developing a new prescription medicine that gains marketing approval is estimated to cost drugmakers $2.6 billion according to a…

The Amgen Foundation this week announced that its “Amgen Scholars Program” is expanding its presence with new host institutions in…

On Wednesday, November 12, HHS Secretary Sylvia Burwell and Homeland Security Secretary Jeh Johnson will appear before the Senate…

  Silicon Valley has been interested in the healthcare industry for many years. Genetic testing startup 23andMe’s battle with the…